Literature DB >> 23613036

A novel treatment-responsive encephalitis with frequent opsoclonus and teratoma.

Thaís Armangue1, Maarten J Titulaer, Lidia Sabater, Javier Pardo-Moreno, Nuria Gresa-Arribas, Natalia Barbero-Bordallo, Gordon R Kelley, Noh Kyung-Ha, Akitoshi Takeda, Takahiro Nagao, Yukitoshi Takahashi, Angélica Lizcano, Aisling S Carr, Francesc Graus, Josep Dalmau.   

Abstract

Among 249 patients with teratoma-associated encephalitis, 211 had N-methyl-D-aspartate receptor antibodies and 38 were negative for these antibodies. Whereas antibody-positive patients rarely developed prominent brainstem-cerebellar symptoms, 22 (58%) antibody-negative patients developed a brainstem-cerebellar syndrome, which in 45% occurred with opsoclonus. The median age of these patients was 28.5 years (range = 12-41), 91% were women, and 74% had full recovery after therapy and tumor resection. These findings uncover a novel phenotype of paraneoplastic opsoclonus that until recently was likely considered idiopathic or postinfectious. The triad of young age (teenager to young adult), systemic teratoma, and high response to treatment characterize this novel brainstem-cerebellar syndrome.
© 2013 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23613036      PMCID: PMC4819999          DOI: 10.1002/ana.23917

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

1.  Opsoclonus-myoclonus syndrome associated with benign ovarian teratoma.

Authors:  A S Fitzpatrick; O M Gray; J McConville; G V McDonnell
Journal:  Neurology       Date:  2008-04-08       Impact factor: 9.910

2.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

3.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

4.  Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates.

Authors:  Beau M Ances; Roberta Vitaliani; Robert A Taylor; David S Liebeskind; Alfredo Voloschin; David J Houghton; Steven L Galetta; Marc Dichter; Abass Alavi; Myrna R Rosenfeld; Josep Dalmau
Journal:  Brain       Date:  2005-05-11       Impact factor: 13.501

5.  Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients.

Authors:  Thaís Armangue; Maarten J Titulaer; Ignacio Málaga; Luis Bataller; Iñigo Gabilondo; Francesc Graus; Josep Dalmau
Journal:  J Pediatr       Date:  2012-11-16       Impact factor: 4.406

6.  Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.

Authors:  Josep Dalmau; Erdem Tüzün; Hai-yan Wu; Jaime Masjuan; Jeffrey E Rossi; Alfredo Voloschin; Joachim M Baehring; Haruo Shimazaki; Reiji Koide; Dale King; Warren Mason; Lauren H Sansing; Marc A Dichter; Myrna R Rosenfeld; David R Lynch
Journal:  Ann Neurol       Date:  2007-01       Impact factor: 10.422

7.  Autoantigen diversity in the opsoclonus-myoclonus syndrome.

Authors:  Luis Bataller; Myrna R Rosenfeld; Francesc Graus; Juan J Vilchez; Nai-Kong V Cheung; Josep Dalmau
Journal:  Ann Neurol       Date:  2003-03       Impact factor: 10.422

8.  Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome.

Authors:  Elizabeth D Tate; Tyler J Allison; Michael R Pranzatelli; Steven J Verhulst
Journal:  J Pediatr Oncol Nurs       Date:  2005 Jan-Feb       Impact factor: 1.636

9.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

10.  AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.

Authors:  Meizan Lai; Ethan G Hughes; Xiaoyu Peng; Lei Zhou; Amy J Gleichman; Huidy Shu; Sabrina Matà; Daniel Kremens; Roberta Vitaliani; Michael D Geschwind; Luis Bataller; Robert G Kalb; Rebecca Davis; Francesc Graus; David R Lynch; Rita Balice-Gordon; Josep Dalmau
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

View more
  19 in total

1.  Paraneoplastic opsoclonus and cerebellar ataxia related to anti-Ma2 antibody: a case report.

Authors:  Nicolas Mélé; Charlotte Hautefort; Alain Toledano; Jean-Yves Delattre; Dimitri Psimaras
Journal:  J Neurol       Date:  2016-01-11       Impact factor: 4.849

2.  Opsoclonus-myoclonus syndrome in a patient with an anaplastic oligoastrocytoma.

Authors:  Carl A Gold; Andrew B Lassman; Yazmín Odia
Journal:  J Neurooncol       Date:  2015-04-12       Impact factor: 4.130

Review 3.  Autoimmune encephalitis and its relation to infection.

Authors:  Arun Venkatesan; David R Benavides
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

4.  Anti-N-methyl-D-aspartate receptor encephalitis with lung adenocarcinoma.

Authors:  Ying-Ying Wu; Xian-Jun He; Mi-Lan Zhang; Ying-Ying Shi; Jie-Wen Zhang
Journal:  Neurol Sci       Date:  2016-03-30       Impact factor: 3.307

5.  Clinical Reasoning: A 16-year-old girl with ataxia, oscillopsia, and behavioral changes.

Authors:  Andrew Silverman; Chindhuri Selvadurai; John Picard; Lauren Gluck; Adeniyi Fisayo; Naila Makhani; Viviana Benitez
Journal:  Neurology       Date:  2020-03-31       Impact factor: 9.910

6.  Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.

Authors:  Thaís Armangué; Lidia Sabater; Estefanía Torres-Vega; Eugenia Martínez-Hernández; Helena Ariño; Mar Petit-Pedrol; Jesús Planagumà; Luis Bataller; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2016-04       Impact factor: 18.302

Review 7.  Novelties in Autoimmune and Paraneoplastic Cerebellar Ataxias: Twenty Years of Progresses.

Authors:  Sergio Muñiz-Castrillo; Alberto Vogrig; Nicolás Lundahl Ciano-Petersen; Macarena Villagrán-García; Bastien Joubert; Jérôme Honnorat
Journal:  Cerebellum       Date:  2022-01-12       Impact factor: 3.648

8.  Absence of GluD2 Antibodies in Patients With Opsoclonus-Myoclonus Syndrome.

Authors:  Mar Petit-Pedrol; Mar Guasp; Thais Armangue; Cinzia Lavarino; Andres Morales La Madrid; Albert Saiz; Francesc Graus; Josep Dalmau
Journal:  Neurology       Date:  2020-12-21       Impact factor: 9.910

9.  Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes.

Authors:  Francesc Graus; Alberto Vogrig; Sergio Muñiz-Castrillo; Jean-Christophe G Antoine; Virginie Desestret; Divyanshu Dubey; Bruno Giometto; Sarosh R Irani; Bastien Joubert; Frank Leypoldt; Andrew McKeon; Harald Prüss; Dimitri Psimaras; Laure Thomas; Maarten J Titulaer; Christian A Vedeler; Jan J Verschuuren; Josep Dalmau; Jerome Honnorat
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-05-18

10.  Ovarian teratoma-associated anti-NMDAR encephalitis: a systematic review of reported cases.

Authors:  Pedro Acién; Maribel Acién; Eva Ruiz-Maciá; Carlos Martín-Estefanía
Journal:  Orphanet J Rare Dis       Date:  2014-10-14       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.